DXM + Other strong CYP3A inhibitors, including cobicistat, azoles, clarithromycin

Group assessment

This PHI covers the named group; its members do not have separate PHI ratings.

PHI 3 to 6

https://dxm-atlas.org/en/interactions/other-strong-cyp3a-inhibitors/

Compare

Key points for this combination

Reduced processing through an alternative metabolic pathway. Effects differ across this group [24].

General concepts in this text

Drug metabolism

Chemical transformation of a medicine in the body.

The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.

Sources: Drug metabolism

How well is this understood?

Mechanism confidence: medium

Confidence in the mechanism: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: low

Confidence in direct human evidence involving DXM: low

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: 3A — CYP3A metabolism
ⓘ

CYP3A

A group of related CYP enzymes involved in the chemical transformation of medicines.

CYP3A is an enzyme group that includes CYP3A4 and CYP3A5.

Sources: CYP3A

Sources

Check the review’s wording

Reduced alternative metabolism; heterogeneous effects [24]

Combination row in the review: 3A — CYP3A metabolism

Related entries

Reference

Open the source and related combinations →